Abstract
In this issue of Immunity, Liao etal. (2013) utilize monoclonal antibodies isolated from RV144 vaccinees to gain key insights into the structural vulnerabilities of the V1-V2 loops of HIV gp120 protein and how they might be associated with vaccine efficacy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have